彭布拉医疗
PEN
320.86
-0.34
-0.11%
彭布拉医疗
US · PEN
#1275 按市值排名
上市于 2015
320.86
-0.34
-0.11%
实时 - 追踪5344个代码 - 心跳于511秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 最近一期（2026/Q3）披露持股的机构数量减少了2家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 88.05% +0.08pp
- 机构数量
- 530 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund47.40%
Hedge Fund28.36%
Public Company7.36%
Individual/Insider2.76%
Sovereign Wealth Fund1.91%
Private Company1.28%
Government Pension Fund1.23%
Insurance Company0.26%
Other9.35%
主要股东 截至 2026-06-30
BlackRock
10.91% · 4.30M 股
Vanguard Capital Management, LLC
4.98% · 1.96M 股
HBK Investments L.P.
4.67% · 1.84M 股
Vanguard Portfolio Management, LLC
4.23% · 1.67M 股
State Street Global Advisors
3.16% · 1.24M 股
ExodusPoint Capital Management, LP
2.77% · 1.09M 股
Balyasny Asset Management L.P.
2.77% · 1.09M 股
JPMorgan Chase & Co.
2.42% · 952.40K 股
Arrowstreet Capital, Limited Partnership
2.12% · 834.90K 股
UBS Asset Management
2.03% · 801.51K 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 14次买入 · 36次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Adam Elsesser | Chairperson & CEO | 1.73% |
| Arani Bose | Co-Founder | 0.66% |
| Johanna Roberts | General Counsel | 0.13% |
| Shruthi Narayan | Executive VP & GM of Interventional | 0.08% |
| Lambert Shiu | Chief Accounting Officer | 0.07% |
| Harpreet Grewal | Independent Director | 0.02% |
| Janet Leeds | Independent Director | 0.02% |
| Bridget O’Rourke | Independent Director | 0.01% |
| Maggie Yuen | Chief Financial Officer | 0.01% |
| Thomas Wilder | Independent Director | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-14 | Shruthi Narayan | Executive VP & GM of Interventional | Sale to Issuer | -1,230 | $318.43 |
| 2026-08-16 | Shruthi Narayan | Executive VP & GM of Interventional | Other Acquisition | +3,060 | -- |
| 2026-05-18 | Adam Elsesser | Chairperson & CEO | Other Disposition | -77,000 | -- |
| 2026-04-01 | Harpreet Grewal | Independent Director | Automatic Disposition | -100 | $328.22 |
| 2026-03-14 | Maggie Yuen | Chief Financial Officer | Sale to Issuer | -186 | $336.18 |
| 2026-03-14 | Johanna Roberts | General Counsel | Sale to Issuer | -186 | $336.18 |
| 2026-03-14 | Lambert Shiu | Chief Accounting Officer | Sale to Issuer | -150 | $336.18 |
| 2026-03-14 | Shruthi Narayan | Executive VP & GM of Interventional | Sale to Issuer | -117 | $336.18 |
| 2026-03-01 | Maggie Yuen | Chief Financial Officer | Automatic Disposition | -2,432 | $342.30 |
| 2026-02-16 | Maggie Yuen | Chief Financial Officer | Other Acquisition | +5,260 | -- |
| 2026-02-16 | Johanna Roberts | General Counsel | Other Acquisition | +5,260 | -- |
| 2026-02-16 | Lambert Shiu | Chief Accounting Officer | Other Acquisition | +4,600 | -- |
| 2026-02-16 | Shruthi Narayan | Executive VP & GM of Interventional | Other Acquisition | +5,260 | -- |
| 2026-02-14 | Maggie Yuen | Chief Financial Officer | Sale to Issuer | -481 | $339.30 |
| 2026-02-14 | Johanna Roberts | General Counsel | Sale to Issuer | -482 | $339.30 |
| 2026-02-14 | Lambert Shiu | Chief Accounting Officer | Sale to Issuer | -412 | $339.30 |
| 2026-02-14 | Shruthi Narayan | Executive VP & GM of Interventional | Sale to Issuer | -705 | $339.30 |
| 2026-02-12 | Harpreet Grewal | Independent Director | Other Acquisition | +589 | -- |
| 2026-02-12 | Arani Bose | Co-Founder | Other Acquisition | +589 | -- |
| 2026-02-12 | Thomas Wilder | Independent Director | Other Acquisition | +589 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:25 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
彭布拉医疗 讨论区 0 条评论